Nafamostat Mesylate (Ensysce Biosciences)
甲磺酸萘莫司他 (Ensysce Biosciences)
Report date: 2025/10/27 17:55:53
Base Information
Drug NameNafamostat Mesylate (Ensysce Biosciences)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesEnsysce Biosciences Inc
China Registration ClassN/A
Develop Information
Active CompaniesEnsysce Biosciences Inc
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A